1. Home
  2. EXAS vs RCI Comparison

EXAS vs RCI Comparison

Compare EXAS & RCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.91

Market Cap

19.3B

Sector

Health Care

ML Signal

HOLD

Logo Rogers Communication Inc.

RCI

Rogers Communication Inc.

HOLD

Current Price

$37.89

Market Cap

19.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXAS
RCI
Founded
1995
1960
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical Specialities
Cable & Other Pay Television Services
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
19.3B
19.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EXAS
RCI
Price
$101.91
$37.89
Analyst Decision
Buy
Hold
Analyst Count
20
2
Target Price
$77.94
$34.50
AVG Volume (30 Days)
4.9M
981.4K
Earning Date
02-18-2026
01-29-2026
Dividend Yield
N/A
3.83%
EPS Growth
N/A
341.45
EPS
N/A
8.96
Revenue
$3,082,033,000.00
$15,091,643,989.00
Revenue This Year
$19.40
$7.48
Revenue Next Year
$13.51
$5.58
P/E Ratio
N/A
$4.19
Revenue Growth
14.47
2.75
52 Week Low
$38.81
$23.18
52 Week High
$102.66
$40.26

Technical Indicators

Market Signals
Indicator
EXAS
RCI
Relative Strength Index (RSI) 85.29 57.40
Support Level $101.45 $37.20
Resistance Level $102.00 $37.46
Average True Range (ATR) 0.39 0.52
MACD -1.26 0.14
Stochastic Oscillator 88.69 94.88

Price Performance

Historical Comparison
EXAS
RCI

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About RCI Rogers Communication Inc.

Rogers Communications is the largest wireless service provider in Canada with more than 11 million subscribers, equating to one-third of the total Canadian market. Rogers' wireless business accounts for more than half of total revenue and has been growing at a higher rate than other segments. The cable segment, which provides about 38% of total revenue after acquiring Shaw, offers home internet, television, and landline phone service to consumers and businesses. Remaining sales come from Rogers' media unit, which owns and operates various television and radio stations and the Toronto Blue Jays. Rogers' significant exposure to sports also includes ownership stakes in the Maple Leafs, Raptors, Toronto FC, and Argonauts.

Share on Social Networks: